(Q40828601)

24 September 2017

title

Management of the patient with progressive radioiodine non-responsive disease (English)

1 reference

24 September 2017

1 reference

Haugen BR

1

1 reference

24 September 2017

language of work or name

1 reference

1 January 1999

1 reference

Journal of Surgical Oncology

24 September 2017

published in

1 reference

24 September 2017

volume

16

1 reference

24 September 2017

issue

1

1 reference

24 September 2017

page(s)

34-41

1 reference

24 September 2017

cites work

Cancer statistics, 1998.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2388%28199901%2F02%2916%3A1%3C34%3A%3AAID-SSU7%3E3.0.CO%3B2-2

Chemotherapy of thyroid cancer with adriamycin. Experience with 30 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2388%28199901%2F02%2916%3A1%3C34%3A%3AAID-SSU7%3E3.0.CO%3B2-2

A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2388%28199901%2F02%2916%3A1%3C34%3A%3AAID-SSU7%3E3.0.CO%3B2-2

All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2388%28199901%2F02%2916%3A1%3C34%3A%3AAID-SSU7%3E3.0.CO%3B2-2

All-trans, 13-cis and 9-cis retinoic acids induce a fully reversible growth inhibition in HNSCC cell lines: implications for in vivo retinoic acid use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2388%28199901%2F02%2916%3A1%3C34%3A%3AAID-SSU7%3E3.0.CO%3B2-2

Effects of 13 cis-retinoic acid on growth and differentiation of human follicular carcinoma cells (UCLA R0 82 W-1) in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2388%28199901%2F02%2916%3A1%3C34%3A%3AAID-SSU7%3E3.0.CO%3B2-2

Retinoic acid-induced decrease of DNA synthesis and peroxidase mRNA levels in human thyroid cells expressing retinoic acid receptor alpha mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2388%28199901%2F02%2916%3A1%3C34%3A%3AAID-SSU7%3E3.0.CO%3B2-2

RXR gamma null mice are apparently normal and compound RXR alpha +/-/RXR beta -/-/RXR gamma -/- mutant mice are viable.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2388%28199901%2F02%2916%3A1%3C34%3A%3AAID-SSU7%3E3.0.CO%3B2-2

Effects of retinoids and role of retinoic acid receptors in human thyroid carcinomas and cell lines derived therefrom

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2388%28199901%2F02%2916%3A1%3C34%3A%3AAID-SSU7%3E3.0.CO%3B2-2

Dose response evaluation of adriamycin in human neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2388%28199901%2F02%2916%3A1%3C34%3A%3AAID-SSU7%3E3.0.CO%3B2-2

Modified administration schedule of Adriamycin in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2388%28199901%2F02%2916%3A1%3C34%3A%3AAID-SSU7%3E3.0.CO%3B2-2

Results of chemotherapy in thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2388%28199901%2F02%2916%3A1%3C34%3A%3AAID-SSU7%3E3.0.CO%3B2-2

10.1002/(SICI)1098-2388(199901/02)16:1<34::AID-SSU7>3.0.CO;2-2

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference